levonorgestrel has been researched along with Bleeding Between Periods in 75 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (6.67) | 18.7374 |
| 1990's | 3 (4.00) | 18.2507 |
| 2000's | 20 (26.67) | 29.6817 |
| 2010's | 37 (49.33) | 24.3611 |
| 2020's | 10 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YY; Cheng, LY; Chu, LC; Lan, KC; Ou, YC; Tsai, CC | 1 |
| Dincgez, B; Ketenci Gencer, F; Yuksel, S | 1 |
| Jensen, JT; Kroll, R; Lukkari-Lax, E; Schulze, A; Serrani, M; Wahdan, Y | 1 |
| Bertelsen, PK; Heinemeier, IIK; Kragsig Thomsen, T; Messerschmidt, L; Rudnicki, M | 1 |
| Costescu, D; Fels, LM; Hofmann, BM; Klein, S; Lindenthal, B; Lukkari-Lax, E; Peipert, JF; Reinecke, I; Speer, R; Vieira, CS; Wiesinger, K | 1 |
| He, C; He, X; Huirne, JAF; Ji, S; Liang, Y; Mol, BW; Tian, Y; Wang, Y; Xia, W; Xie, L; Yan, L; Zhang, J; Zhu, C; Zhu, Q | 1 |
| Boniface, E; Edelman, A; Han, L; Jensen, JT; Messerle-Forbes, M; O'Donnell, A; Schrote, K | 1 |
| Gao, X; Hubacher, D; Maldonado, LY; Sergison, JE | 1 |
| Bongers, MY; Bui, BN; der Heijden, PAHHV; Geomini, PMAJ; Veersema, S | 1 |
| Ahlers, C; Beckert, V; Frenz, AK; Friede, T; Gerlinger, C | 1 |
| Black, K; Bolnga, J; Gupta, S; Jenkins, G; Mola, G; Ramsay, P; Stein, W | 1 |
| Barra, F; Ferrero, S; Leone Roberti Maggiore, U; Scala, C; Venturini, PL | 1 |
| Gemzell-Danielsson, K; Kopp Kallner, H; Papaikonomou, K; Söderdahl, F | 1 |
| Chen, PH; Choudhury, T; Frondelli, M; Goldman, AR; Shimoni, N | 1 |
| Creinin, MD; Goldthwaite, LM | 1 |
| Bistervels, IM; Hamulyák, EN; Middeldorp, S; Scheres, LJJ | 1 |
| Cohen, MA; Edelman, AB; Jensen, JT; Simmons, KB | 1 |
| Cibula, D; Dundr, P; Hrazdirova, L; Kubinova, K; Kuzel, D; Mara, M | 1 |
| Graham, CA; Panicker, S; Shawe, J; Stephenson, J | 1 |
| Soper, DE | 1 |
| Draeby, J; Inki, P; O'Flynn, M; Schmelter, T; Sørdal, T | 1 |
| Giacobbe, V; Palmara, V; Retto, A; Santoro, G; Sturlese, E; Villari, D | 1 |
| Bateson, D; McGeechan, K; Mohapatra, L; Weisberg, E | 1 |
| Chiti, Z; Dehghani, A; Dehghani-Firoozabadi, R; Dehghani-Firoozabadi, Z; Karimi-Zarchi, M; Miratashi-Yazdi, A; Tabatabaie, A; Teimoori, S | 1 |
| Gemzell-Danielsson, K; Heikinheimo, O; Inki, P; Schmelter, T | 1 |
| Bangerter, K; Kroll, R; Lynen, R; Merz, M | 1 |
| Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
| Bilgehan, F; Deveci, CD; Dilbaz, B; Karadag, B | 1 |
| Apter, D; Beekman, L; Coelingh Bennink, HJ; Foidart, JM; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
| Dahiya, K; Dahiya, P; Dalal, M; Jain, S; Silan, V; Yadav, A | 1 |
| Fan, G; Kang, S; Lukkari-Lax, E; Ren, M; Roth, K; Shin, S; Weisberg, E | 1 |
| Chuah, I; Maguire, AM; Matthews, K; McRae, A; Steinbeck, K | 1 |
| Archer, DF; Bacon, J; Cullins, V; Levine, AS; Philput, CB; Stovall, TG; Weber, ME | 1 |
| Freeman, SB | 1 |
| Gompel, A | 1 |
| Loisel, C; Marpeau, L; Puscasiu, L; Roman, H; Sentilhes, L | 1 |
| Hill, DA | 1 |
| Hait, H; Kaunitz, AM; Portman, DJ; Reape, KZ | 1 |
| Archer, DF; Ballagh, SA; Choksuchat, C; Kovalevsky, GA; Zhao, S; Zhao, Y | 1 |
| Ahrendt, HJ; Makalová, D; Mansour, D; Mellinger, U; Parke, S | 1 |
| Brenner, RM; Critchley, HO; Glasier, AF; Guttinger, A; Lee, RJ; Nickerson, S; Warner, P | 1 |
| Apter, D; Constantine, GD; Emerich, J; Greven, K; Grubb, GS; Klasa-Mazurkiewicz, D; Melis, GB; Spaczynski, M; Spielmann, D; Teichmann, A | 1 |
| Boubli, L; Gemzell-Danielsson, K; Heikinheimo, O; Inki, P; Kunz, M; O'Flynn, M | 1 |
| Kashanian, M; Shahpourian, F; Zare, O | 1 |
| Agarwal, N; Kriplani, A; Kulshrestha, V; Lal, S; Sharma, M | 1 |
| Gemzell-Danielsson, K; Heikinheimo, O; Inki, P; Kunz, M | 1 |
| Givens, V; Harraway-Smith, CL; Maness, DL; Mitchell, G; Reddy, A | 1 |
| Arbat, A; Brosa, M; Crespo, C; Cristóbal, I; Febrer, L; Hernández, FJ; Lete, I | 1 |
| Constantine, GD; Fortier, MP; Grubb, GS; Mirkin, S; Reid, RL; Smith, L | 1 |
| Blumenthal, PD; Dawson, L; Hurskainen, R | 1 |
| Allsworth, JE; Madden, T; Peipert, JF; Proehl, S; Secura, GM | 1 |
| Carlson, NE; Edelman, A; Forbes, MM; Jensen, J; Kaneshiro, B; Nichols, M | 1 |
| Carlson, NE; Edelman, A; Jensen, J; Kaneshiro, B; Nichols, M | 1 |
| Bouchard, P | 1 |
| Bahamondes, L; Bahamondes, MV | 1 |
| Archer, DF | 1 |
| Blum, M; Gelernter, I; Werchow, M | 1 |
| Arshat, H | 1 |
| Gonzalez-ansorena, R; Rubio-lotvin, B; Ruiz-moreno, JA | 1 |
| Anhst-horridge, A; Richter, RH; Riemann-hunziker, R; Roth, F; Sprenger, S; Turpeinen, K | 1 |
| Espié, M | 1 |
| Bahamondes, L; Oliveira-Ribeiro, M; Peloggia, A; Petta, CA; Salamonsen, L; Zhang, J | 1 |
| Phupong, V; Sophonsritsuk, A; Taneepanichskul, S | 1 |
| Dadhwal, V; Deka, D; Gupta, B; Misra, R; Mittal, S | 1 |
| Constantine, GD; Grubb, GS; Johnson, JV | 1 |
| Trussell, J | 1 |
| Fraser, IS; Kaitu'u-Lino, TJ; Morison, NB; Salamonsen, LA; Zhang, J | 1 |
| Critchley, HO; Guttinger, A | 1 |
| Costales, AC; Jensen, JT; Nelson, AL | 1 |
| Archer, DF; Jensen, JT | 1 |
| Heikkilä, M | 1 |
| Archer, DF; DelConte, A; Maheux, R; O'Brien, FB | 1 |
| Bianchi, S; Fedele, L; Gammaro, L | 1 |
| Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
9 review(s) available for levonorgestrel and Bleeding Between Periods
| Article | Year |
|---|---|
Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year after insertion: a systematic review and meta-analysis.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Time Factors | 2020 |
Sex matters: Practice 5P's when treating young women with venous thromboembolism.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Heparin, Low-Molecular-Weight; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Recurrence; Risk Factors; Sex Factors; Stockings, Compression; Thrombophilia; Thrombophlebitis; Tranexamic Acid; Travel; Uterine Hemorrhage; Venous Thromboembolism; Young Adult | 2019 |
Continuous oral contraception. Strategies for managing breakthrough bleeding.
Topics: Aftercare; Contraceptives, Oral, Combined; Counseling; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Metrorrhagia; Nurse Practitioners; Patient Education as Topic; Primary Health Care | 2008 |
How best to manage dysfunctional uterine bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Contraceptive Agents, Female; Danazol; Diagnosis, Differential; Endometrium; Estrogen Antagonists; Female; Humans; Intrauterine Devices; Levonorgestrel; Medical History Taking; Metrorrhagia; Risk Factors; Ultrasonography | 2010 |
Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
Current and future medical treatments for menometrorrhagia during the premenopause.
Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2011 |
Vascular dysfunction as a cause of endometrial bleeding.
Topics: Contraceptives, Oral, Synthetic; Endometrium; Female; Humans; Levonorgestrel; Menorrhagia; Metrorrhagia | 2012 |
Endometrial effects of intrauterine levonorgestrel.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Matrix Metalloproteinases; Metrorrhagia; Receptors, Steroid | 2007 |
Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms.
Topics: Animals; Chemistry, Pharmaceutical; Contraceptive Agents, Female; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Metrorrhagia | 2008 |
31 trial(s) available for levonorgestrel and Bleeding Between Periods
| Article | Year |
|---|---|
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia | 2023 |
Comparing levonorgestrel intrauterine system with hysteroscopic niche resection in women with postmenstrual spotting related to a niche in the uterine cesarean scar: a randomized, open-label, controlled trial.
Topics: China; Cicatrix; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Metrorrhagia; Pelvic Pain; Pregnancy; Uterus | 2023 |
Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
Topics: Contraception; Contraceptive Agents, Female; Curcumin; Female; Humans; Levonorgestrel; Metrorrhagia; Pregnancy; Uterine Hemorrhage | 2023 |
Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Double-Blind Method; Female; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Mifepristone; Prospective Studies; Young Adult | 2018 |
Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Linear Models; Metrorrhagia; Tamoxifen; Young Adult | 2019 |
Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Metrorrhagia; Prospective Studies; Tranexamic Acid | 2013 |
A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Fertility Preservation; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Metrorrhagia; Middle Aged; Ultrasonography; Young Adult | 2013 |
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menorrhagia; Menstrual Cycle; Metrorrhagia; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; United States; Young Adult | 2015 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
Topics: Abortion, Induced; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Pregnancy; Young Adult | 2015 |
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estetrol; Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Nandrolone | 2016 |
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; India; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; Patient Acceptance of Health Care; Severity of Illness Index | 2016 |
A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population.
Topics: Adolescent; Adult; Australia; China; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Pregnancy; Pregnancy Rate; Republic of Korea; Treatment Outcome; Young Adult | 2017 |
Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users.
Topics: Analgesics; Contraceptive Agents, Female; Double-Blind Method; Drug Implants; Estrogens; Ethinyl Estradiol; Female; Humans; Ibuprofen; Levonorgestrel; Metrorrhagia; Placebos; Treatment Outcome | 2008 |
Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant.
Topics: Adult; Double-Blind Method; Doxycycline; Endometrium; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Infusions, Subcutaneous; Levonorgestrel; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metrorrhagia; Prospective Studies; Tissue Inhibitor of Metalloproteinase-1; Young Adult | 2009 |
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Metrorrhagia; Middle Aged; Nandrolone; Patient Satisfaction; Treatment Outcome; Young Adult | 2009 |
Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Middle Aged; Norpregnadienes; Receptors, Progesterone | 2010 |
Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Metrorrhagia; Middle Aged; Patient Selection; Pregnancy, Unplanned; Statistics, Nonparametric | 2009 |
Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)--a multicentre prospective study.
Topics: Adult; Device Removal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menstruation; Metrorrhagia; Prospective Studies; Safety | 2010 |
A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran.
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Iran; Levonorgestrel; Metrorrhagia; Nausea; Patient Satisfaction | 2010 |
Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Middle Aged; Mifepristone; Patient Satisfaction; Prospective Studies; Vagina; Young Adult | 2010 |
Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Estradiol; Estrogens; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Naproxen; Treatment Outcome | 2012 |
A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Contraceptives, Oral, Combined; Double-Blind Method; Doxycycline; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Treatment Outcome | 2012 |
Assessment of the use of two new low-dose levonorgestrel-releasing intrauterine systems as contraceptives.
Topics: Adult; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Europe; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Pregnancy; Pregnancy, Unplanned; Time Factors; Treatment Outcome | 2012 |
The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use.
Topics: Adult; Antifibrinolytic Agents; Double-Blind Method; Drug Implants; Female; Humans; Levonorgestrel; Metrorrhagia; Prospective Studies; Tranexamic Acid | 2006 |
Levonorgestrel-releasing intrauterine system vs. transcervical endometrial resection for dysfunctional uterine bleeding.
Topics: Adult; Contraceptive Agents, Female; Dilatation and Curettage; Drug Implants; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Patient Satisfaction; Treatment Outcome; Ultrasonography | 2006 |
Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 micro g/ethinyl estradiol 20 micro g.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Endometrium; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Safety; Treatment Outcome | 2007 |
Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Kaplan-Meier Estimate; Levonorgestrel; Metrorrhagia; Middle Aged; Patient Compliance; Patient Satisfaction; United States | 2008 |
Puerperal insertion of a copper-releasing and a levonorgestrel-releasing intrauterine contraceptive device.
Topics: Adult; Breast Feeding; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Metrorrhagia; Middle Aged; Migraine Disorders; Norgestrel; Postpartum Period; Pregnancy | 1982 |
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Headache; Humans; Incidence; Levonorgestrel; Life Tables; Menstruation; Metrorrhagia; Middle Aged; Patient Compliance; Patient Dropouts; Pregnancy; Pregnancy Rate; Safety; Uterine Cervical Neoplasms; Uterine Hemorrhage | 1997 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
35 other study(ies) available for levonorgestrel and Bleeding Between Periods
| Article | Year |
|---|---|
Levonorgestrel intrauterine system for the treatment of intermenstrual spotting in patients with previous cesarean delivery scar defect.
Topics: Cicatrix; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Pregnancy; Retrospective Studies | 2022 |
Levonorgestrel-Releasing Intrauterine Device Use Can Be a Treatment Option in Symptomatic Patients with Isthmocele.
Topics: Dysmenorrhea; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Prospective Studies | 2022 |
Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Pregnancy | 2022 |
Impact of combined endometrial resection or ablation and levonorgestrel intrauterine device on postoperative bleeding pattern.
Topics: Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Prospective Studies | 2023 |
Is there evidence to treat bleeding disturbances during long-term 52 mg LNG-IUS use with estrogen?
Topics: Adult; Contraception Behavior; Contraceptive Agents, Hormonal; Estrogens; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Patient Satisfaction; Time Factors; Young Adult | 2020 |
Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Long-Acting Reversible Contraception; Menstruation; Menstruation Disturbances; Metrorrhagia; Predictive Value of Tests | 2021 |
Twelve month follow-up of a contraceptive implant outreach service in rural Papua New Guinea.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Papua New Guinea; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Pregnancy Rate; Rural Population; Surveys and Questionnaires; Young Adult | 2017 |
Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique
Topics: Adult; Contraceptives, Oral, Synthetic; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Incidence; Intention to Treat Analysis; Intestinal Diseases; Italy; Levonorgestrel; Metrorrhagia; Norethindrone; Norethindrone Acetate; Ovarian Diseases; Pain Measurement; Patient Dropouts; Patient Preference; Pelvic Pain; Prospective Studies; Vaginal Diseases | 2018 |
Bleeding and spotting with the levonorgestrel 13.5 mg intrauterine system: the impact of insertion timing.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Multivariate Analysis; New Jersey; Pregnancy; Pregnancy, Unplanned; Regression Analysis; Time Factors; Uterine Hemorrhage; Young Adult | 2019 |
Comparing bleeding patterns for the levonorgestrel 52 mg, 19.5 mg, and 13.5 mg intrauterine systems.
Topics: Amenorrhea; Dose-Response Relationship, Drug; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia | 2019 |
Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system.
Topics: Adult; Cohort Studies; Device Removal; Feasibility Studies; Female; Follow-Up Studies; Humans; Hysteroscopy; Intrauterine Device Migration; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Middle Aged; Pelvic Pain; Young Adult | 2013 |
Women's experiences with tailored use of a combined oral contraceptive: a qualitative study.
Topics: Adolescent; Adult; Contraception; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Randomized Controlled Trials as Topic | 2013 |
The intrauterine device: a good thing revisited.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Biomedical Research; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Metrorrhagia; Pelvic Inflammatory Disease; Tamoxifen; Tranexamic Acid | 2013 |
Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding: a 6- and 12-month morphological and clinical follow-up.
Topics: Adult; Endometrial Hyperplasia; Endometrium; Female; Follow-Up Studies; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Middle Aged; Quality of Life; Ultrasonography | 2013 |
A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
Topics: Adult; Age Factors; Amenorrhea; Australia; Contraception; Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Longitudinal Studies; Marital Status; Metrorrhagia; Parity; Patient Satisfaction; Young Adult | 2014 |
Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Middle Aged; Patient Satisfaction; Prospective Studies | 2014 |
Menstrual management in developmentally delayed adolescent females.
Topics: Adolescent; Adolescent Behavior; Anti-Inflammatory Agents, Non-Steroidal; Caregivers; Child; Child Behavior; Contraceptives, Oral, Combined; Developmental Disabilities; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menarche; Menstruation; Metrorrhagia; Parents; Retrospective Studies | 2017 |
[Treatment of metrorrhagia, breakthrough bleeding and spotting under contraceptives].
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Drug Implants; Estrogens; Female; Humans; Levonorgestrel; Metrorrhagia; Progestins; Uterine Hemorrhage | 2008 |
[Management of menometrorrhagia in women with and without pregnancy intention: hierarchy of therapies].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Hormonal; Embolization, Therapeutic; Endometrial Hyperplasia; Estrogens; Female; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Levonorgestrel; Metrorrhagia; Polyps; Pregnancy; Progestins; Tranexamic Acid; Uterine Neoplasms; Uterus | 2008 |
Abnormal uterine bleeding: avoid the rush to hysterectomy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Contraceptive Agents, Female; Danazol; Diagnosis, Differential; Drug Therapy, Combination; Endometrial Ablation Techniques; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Metrorrhagia; Minimally Invasive Surgical Procedures; Practice Guidelines as Topic; Pregnancy Tests; Progestins; Treatment Outcome; Uterine Hemorrhage | 2009 |
Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Metrorrhagia; Retrospective Studies; Young Adult | 2009 |
Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system.
Topics: Adult; Age Factors; Female; Health Surveys; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Patient Satisfaction; Prospective Studies; Surveys and Questionnaires | 2010 |
Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cost-Benefit Analysis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Models, Theoretical; Progestins; Quality of Life; Spain | 2011 |
Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
Topics: Adolescent; Adult; Amenorrhea; Canada; Clinical Trials, Phase III as Topic; Contraceptives, Oral, Combined; Dosage Forms; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Menorrhagia; Metrorrhagia; Middle Aged; Multicenter Studies as Topic; Patient Satisfaction; Young Adult | 2010 |
Unscheduled bleeding with continuous oral contraceptive pills: a comparison of progestin dose.
Topics: Adult; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Metrorrhagia; Progestins; Young Adult | 2012 |
Effect of oral contraception by progesterone pill on lipids and glucose metabolism.
Topics: Biology; Carbohydrates; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Diagnosis; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Glucose Tolerance Test; Levonorgestrel; Lipids; Lynestrenol; Mestranol; Metabolism; Metrorrhagia; Parity; Physiology; Reproductive Control Agents; Research | 1983 |
A comparative study of Loestrin versus Nordette in Kelantan, West Malaysia.
Topics: Asia; Asia, Southeastern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Data Collection; Developing Countries; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Levonorgestrel; Malaysia; Menstruation Disturbances; Metrorrhagia; Norethindrone; Patient Acceptance of Health Care; Physiology; Research; Sampling Studies; Signs and Symptoms; Statistics as Topic | 1984 |
Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
Topics: Americas; Biology; Blood; Blood Pressure; Body Weight; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developing Countries; Diagnosis; Disease; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Latin America; Levonorgestrel; Lipids; Menstrual Cycle; Menstruation; Metrorrhagia; Mexico; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Signs and Symptoms | 1992 |
[Experience with three minipills preparations with low dose progestagens for oral contraception].
Topics: Behavior; Central Nervous System; Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Digestive System; Disease; Family Planning Services; Hemorrhage; Levonorgestrel; Libido; Megestrol Acetate; Metrorrhagia; Nausea; Research; Sexual Behavior; Signs and Symptoms | 1970 |
[Tamoxifen, endometrial cancer and levonorgestrel intra-uterine device].
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Tamoxifen; Treatment Outcome | 2003 |
Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system.
Topics: Chemokines; Contraceptive Agents, Female; Endometrium; Female; Humans; Immunochemistry; Intrauterine Devices, Medicated; Killer Cells, Natural; Levonorgestrel; Mast Cells; Metrorrhagia | 2006 |
Bleeding after use of the levonorgestrel regimen of emergency contraception: concordance between women's reports of their menstrual periods and an objective algorithm.
Topics: Adolescent; Adult; Algorithms; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Menstrual Cycle; Metrorrhagia; Time Factors | 2007 |
The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women.
Topics: Animals; Contraceptive Agents, Female; Decidua; Desogestrel; Electrophoresis, Polyacrylamide Gel; Endometrium; Estrogen Receptor alpha; Female; Immunohistochemistry; Intrauterine Devices, Medicated; Killer Cells, Natural; Levonorgestrel; Macrophages; Matrix Metalloproteinase 3; Matrix Metalloproteinase 7; Matrix Metalloproteinase 9; Metrorrhagia; Mice; Mice, Inbred C57BL; Models, Animal; Neutrophils; Organ Size; Receptors, Progesterone; Time Factors; Uterus | 2007 |
Levonorgestrel-releasing intrauterine device and uterine perforations.
Topics: Contraceptive Agents, Female; Female; Foreign-Body Migration; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Uterine Perforation | 2007 |
Levonorgestrel-releasing intrauterine device for the treatment of menometrorrhagia in a woman on hemodialysis.
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Progesterone Congeners; Renal Dialysis | 1999 |